The EU has given Gilead the green light to market its twice-yearly pre-exposure prophylaxis (PrEP) product lenacapavir, which ...

Analysts and charities have identified Gilead’s new HIV prevention injection as key to curbing infection rates ...

Gilead Sciences (NASDAQ:GILD) announced Tuesday that the European Commission has approved its biannual injection for HIV prevention, marking a major regulatory achievement following its U.S. clearance ...

"No, because I am not afraid to die," Barkley told Sports Illustrated's Rick Reilly in 1992. "I have accomplished everything ...

Gilead Sciences won European approval Tuesday for its new twice-annual HIV prevention shot, now called Yeytuo.

The European Commission has granted marketing authorization for Gilead Sciences' twice-yearly injection for preventing HIV infection, the company said on Tuesday.

Robert Suttle, an advocate for the rights of those living with HIV, was sentenced to jail after a former partner accused him ...

For four people living with HIV, speaking up has opened doors to family, community, & a renewed sense of self.

Sherman’s Grand Central Station hosted a HIV & STD testing clinic for underserved and overlooked communities Monday.

Supreme Court's 5-4 ruling cuts nearly $1 billion from NIH funding for minority health research, affecting HIV prevention and ...

Older survivors of HIV require ethical safeguards and autonomy to feel comfortable participating in end-of-life research for a cure for HIV.

Funding will be cut by half for both this and next year’s federal budgets, before he shuts down the President’s Emergency ...